Craft
InnoCare

InnoCare

Total Funding

$215 M

InnoCare Summary

Company summary

Overview
InnoCare is a biopharmaceutical company specializing in drug development for the treatment of cancer and autoimmune diseases. It produces Orelabrutinib, a selective and irreversible small-molecule BTK inhibitor for patients with B-cell malignancies. In addition, the company aims to develop drugs for treating autoimmune diseases induced by T-cell dysfunction.
Type
Private
Founded
2013
HQ
CN | view all locations
Website
http://www.innocarepharma.com/
Cybersecurity rating
Sectors

Key people

  • Jasmine Cui Ph

    Jasmine Cui Ph, Co-Founder President and CEO

    • Rick Xu Ph

      Rick Xu Ph, CMO

      • Shaojing Tong

        Shaojing Tong, CFO

        • Xiangyang Chen Ph

          Xiangyang Chen Ph, CTO

          LocationsView all

          5 locations detected

          • Beijing Shi HQ

            China

            Sheng Ming Ke Xue Yuan Dong Lu, Changping Qu

          • Cambridge, MA

            United States

            1 Broadway

          • Princeton, NJ

            United States

            103 Carnegie Center

          • Nanjing Shi, Jiangsu Sheng

            China

            Long Mian Da Dao, Jiangning Qu

          • Shanghai Shi

            China

            6f, block f, no, 780 Cailun Rd, Pudong Xinqu

          Footer menu